Harpoon Therapeutics

YTD

ALL

Why Robinhood?

You can watch HARP and buy or sell other stocks, ETFs, and their options commission-free!

About HARP

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.

CEO

Dalton E. Smart, MBA, CPA

CEODalton E. Smart, MBA, CPA

Employees

—

Employees—

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

2015

Founded2015

Employees

—

Employees—

HARP Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$23.01

52 Week high$23.01

52 Week low

$23.01

52 Week low$23.01

Stock Snapshot

As of today, Harpoon Therapeutics(HARP) shares are valued at $23.01.

During the trading day, Harpoon Therapeutics(HARP) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Harpoon Therapeutics(HARP) stock has reached 0.

Over the past 52 weeks, Harpoon Therapeutics(HARP) stock has traded between a high of $23.01 and a low of $23.01.

People also own

Based on the portfolios of people who own HARP. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.